WFW advises ING Bank on €19m loan facility to Borusan
FIRM CAPITAL MORTGAGE INVESTMENT CORPORATION CLOSES $23 MILLION BOUGHT DEAL FINANCING
On March 1, 2019, Firm Capital Mortgage Investment Corporation (TSX: FC) announced that it had closed its previously announced bought deal offering of common shares, which includes the exercise in full by the underwriters of their option to purchase additional shares, for gross proceeds of approximately $23 million.
WFW advises Investec on construction financing of subsidy-free 34.7MW tracker solar photovoltaic project
Watson Farley & Williams (“WFW”) has advised Investec Bank plc (“Investec”) on the construction financing for a 34.7MW solar photovoltaic project near York. The loan documentation was signed on 22 February.
The project, which will be constructed by GRIDSERVE WBC Ltd (a subsidiary of GRIDSERVE EMEA Projects Ltd), has a co-located battery and will be fully subsidy-free. Following completion, the project will be sold to Warrington Borough Council to support its green agenda and save on electricity costs.
Osborne Clarke advises BFB Brandenburg Kapital GmbH on investment in Cinuru Research
Osborne Clarke has advised BFB Brandenburg Kapital GmbH, a subsidiary of Brandenburger Förderbank ILB, on its investment in Cinuru Research GmbH. Further investors are Next Media Accelerator (NMA) from Hamburg and a business angel. The seven-figure investment will be used for further growth and technological development of the CRM system for cinemas.
Clifford Chance advises CACEIS on a EUR 188 million public offer for all issued shares and depositary receipts of shares in the capital of Kas Bank
Clifford Chance Amsterdam advised long-term firm client CACEIS, European leader in asset servicing, on a EUR 188 million public offer for all issued shares and depositary receipts of shares in the capital of Kas Bank N.V, a specialist in the field of custody and administration services.
Dexin China Holdings Completes US$189 Million Hong Kong IPO
Hong Kong – Paul Hastings, a leading global law firm, announced today that the firm has advised CCB International Capital Limited as the sole sponsor and sole global coordinator on Dexin China Holdings Company Limited’s (“Dexin China”) US$189 million global offering and IPO on the Main Board of the Hong Kong Stock Exchange.
Proskauer Advises Dolfin Financial on Its Acquisition of Falcon Private Wealth
February 25, 2019 (London) – International law firm Proskauer advised client Dolfin Financial (UK) Ltd (“Dolfin”), an independent, London-based wealth management platform, on its acquisition of the business of Swiss-based Falcon Private Bank’s UK subsidiary, Falcon Private Wealth Ltd.
WFW advises KfW IPEX-Bank on financing of “La Granja Solar” Chilean photovoltaic project
Watson Farley & Williams ("WFW") has advised KfW IPEX-Bank GmbH ("KfW IPEX-Bank") on the US$91m financing for the Granja Solar photovoltaic project near Pozo Almonte in northern Chile. The loan documentation was signed in December 2018.
"La Granja Solar" was developed by Spain's Getxo headquartered Solarpack Corporacion Tecnologica, S.A., which will also be building, owning and operating the project. Following completion, Granja Solar will have a total installed capacity of 123 MWp.
Norton Rose Fulbright advises on the €200 million refinancing of a shopping centre in Warsaw
Global law firm Norton Rose Fulbright has advised Commerzbank AG on the EU200 million loan facility made available to Unibail-Rodamco-Westfield controlled entity for the purpose of refinancing of Galeria Mokotow - one of the largest shopping centres in Warsaw, Poland, opened in September 2000.
Unibail-Rodamco-Westfield is a leading real estate firm involved in real estate investment, development and commercial property management worldwide.
Baker McKenzie advisor to Vator Securities in connection with Ascelia Pharma’s IPO on Nasdaq Stockholm
Ascelia Pharma intends to carry out a new share issue prior to the company’s listing on Nasdaq Stockholm. The share issue is expected to provide Ascelia Pharma with a total of approximately SEK 212 million after deductions for expenses related to the transaction. The first day of trading is expected to be March 13, 2019.
Ascelia Pharma is an oncology-dedicated orphan drug development company located in Malmö, Sweden.